Binding of dopamine and 3-methoxytyramine as l-DOPA metabolites to human alpha(2)-adrenergic and dopaminergic receptors.
Alachkar
Amal
A
Division of Neuroscience, School of Biological Sciences, University of Manchester, Manchester M13 9PT, UK. amalachkar1@yahoo.co.uk
Brotchie
Jonathan M
JM
Jones
Owen T
OT
D000818:Animals; D000978:Antiparkinson Agents / Q000378:metabolism*; D001667:Binding, Competitive / Q000187:drug effects; D001923:Brain Chemistry / Q000187:drug effects; D016466:CHO Cells; D006224:Cricetinae; D003412:Cricetulus; D004298:Dopamine / Q000031:analogs & derivatives* / Q000378:metabolism*; D006801:Humans; D007980:Levodopa / Q000378:metabolism*; D011869:Radioligand Assay; D018341:Receptors, Adrenergic, alpha-2 / Q000187:drug effects / Q000378:metabolism*; D011954:Receptors, Dopamine / Q000187:drug effects / Q000378:metabolism*; D017447:Receptors, Dopamine D1 / Q000187:drug effects / Q000378:metabolism; D017448:Receptors, Dopamine D2 / Q000187:drug effects / Q000378:metabolism; D014162:Transfection
C547768:ADRA2A protein, human; D000978:Antiparkinson Agents; D018341:Receptors, Adrenergic, alpha-2; D011954:Receptors, Dopamine; D017447:Receptors, Dopamine D1; D017448:Receptors, Dopamine D2; D007980:Levodopa; C001746:3-methoxytyramine; D004298:Dopamine